CDMO Services for Pharma Intermediates & APIs Manufacturers

Our aim is to be a reliable supplier and CDMO services provider for pharmaceutical intermediates and APIs

Founded in 1993, SCL Lifesciences has grown into a leading manufacturer of bulk drugs, APIs, and advanced intermediates, serving global pharmaceutical markets. With a strong presence in both international and domestic markets, we cater to a wide range of therapeutic segments, ensuring high-quality pharmaceutical solutions.

Location & Infrastructure

Knowledge Centre: Located at Genome Valley, Hyderabad, India, this state-of-the-art facility focuses on research, development, and innovation.
Manufacturing Units: 2 sites near Chandigarh, India, dedicated to API manufacturing, custom synthesis, and contract development.

Team & Expertise

~100 specialists, including research & analytical scientists, technicians, and project managers at the Knowledge Centre.
~900 professionals, including engineers, scientists, technicians, QA/QC experts, sales teams, and business professionals, ensuring seamless operations.

Facilities & Capabilities

Cutting-edge laboratories:
- Wet & Dry Lab Facility
- Scale-up Facility
- BioLabs (Kg Scale)
- Analytical Labs
Manufacturing Capacity:
- 350KL, including high-pressure reactors, HPAPI, KG, and pilot-scale pharma blocks.
Product Development:
- Advanced APIs, CDMO projects, and specialty chemicals.
- Development of mRNA vaccine ingredients at lab and small-scale levels.

Our manufacturing facilities are compliant to the regulatory standards

WHO Geneva Empanelment
Japanese Pharmaceutical and Medical Devices Agency (JPMDA)
United States Food and Drug Administration (USFDA)
Ministry of Food and Drug Safety (MFDS) Korea
European Directorate for the Quality of Medicines & HealthCare (EDQM)
Therapeutic Goods Administration (TGA) Australia

Why Partner with SCL Lifesciences?

Discover why we are your ideal partner, delivering unmatched expertise, reliability, and innovative solutions.

Global Reach & Market Presence

SCL Lifesciences serves both domestic and international markets, proudly exporting 80% of its products, while maintaining a robust and reliable supply chain.

Over 30 Years of
Excellence

With extensive experience in manufacturing APIs and advanced intermediates, SCL Lifesciences operates two state-of-the-art facilities in Derabassi and Mohali, Punjab, maintaining the highest industry standards, with a 3rd site under-development.

Comprehensive CDMO Services

From development to commercialization, we offer tailored solutions for every stage of the pharmaceutical lifecycle.

Our Journey

We have continually evolved, expanding our reach and making impactful strides in the industry.

1990

Establishment of First Manufacturing Facility

2002

Leading Supplier of Cephalosporin & Penem Intermediates

2004-2008

Milestones in API Manufacturing

API manufacturing site set up First EU GMP Certification of API site in 2005, Subsequent approvals in 2008, 2011, 2012 & 2015

2013

Joint Venture with Mitsubishi Corporation, Japan

2014

SCL Lifesciences receives WHO Geneva GMP approval

2015

AFM registration with PMDA, Japan EU GMP by Danish Medicine, TGA Empanelment

2016-2018

Regulatory Milestones & Growth

USFDA Approval in March '16, '17, '18. WHO GENEVA Empanelment KFDA, First CEP received, Purchase of New Greenfield Site

2019-2021

Second CEP, TGA Empanelment, PMDA approval

2022

SCL Lifesciences ventured into development of Vaccine Ingredients, with proposed pipeline of 25 products

2024

SCL Lifesciences sets up a Knowledge Centre at the Genome Valley in Hyderabad, EDQM certification received

Our Vision

To be a globally recognized pharmaceutical leader, enhancing human life with high-quality products while upholding international health and environmental standards.

Our Mission

We are committed to delivering pure, effective pharmaceutical solutions, leveraging India's expertise to alleviate suffering, and ensuring compliance with global regulations while prioritizing people and the planet.

Our clients say

SCL Lifesciences' has strong reputation across multiple countries establishes its CDMO services as trusted and widely approved by regulatory authorities. This global acknowledgment highlights SCL Lifesciences as a dependable partner, adept at meeting diverse compliance standards and delivering exceptional service in international markets, making it a top choice in the industry.

Diwanshu Goyal

Marketing Manager

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum.

Shyrose Erendil

Digital Marketing Manager

SCL Lifesciences' proven track record across numerous countries reinforces the credibility of its CDMO services, earning widespread trust and approval from regulatory bodies. This international recognition underscores SCL Lifesciences’ reliability in adhering to varied compliance requirements and consistently delivering outstanding solutions, partner in the global market.

John Erendil

Digital Executive

Ready to discuss your needs with us?

Request you to provide all details mentioned in the form along with your business requirement. It will help us route your query to the appropriate person.

Please enter a valid name (only alphabets and spaces allowed).

Please enter your organization name.

Please enter a valid work email address.

Please enter a valid phone number.

Please select your country.

Please enter your message.

By submitting this form you agree to our Privacy Policy concerning the way SCL Lifesciences may use your personal information.

You must agree to the privacy policy.

Company at a Glance